BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24949429)

  • 1. Coexpression of SFRP1 and WIF1 as a prognostic predictor of favorable outcomes in patients with colorectal carcinoma.
    Huang S; Zhong X; Gao J; Song R; Wu H; Zi S; Yang S; Du P; Cui L; Yang C; Li Z
    Biomed Res Int; 2014; 2014():256723. PubMed ID: 24949429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients.
    Liu X; Fu J; Bi H; Ge A; Xia T; Liu Y; Sun H; Li D; Zhao Y
    BMC Cancer; 2019 Dec; 19(1):1212. PubMed ID: 31830937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
    Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; Martínez-Ansó E; Prieto J; Qian C
    Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The negative regulators of Wnt pathway-DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter survival.
    Paluszczak J; Sarbak J; Kostrzewska-Poczekaj M; Kiwerska K; Jarmuż-Szymczak M; Grenman R; Mielcarek-Kuchta D; Baer-Dubowska W
    Tumour Biol; 2015 Apr; 36(4):2855-61. PubMed ID: 25487617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
    Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
    J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Relevance of SFRP1 Gene Promoter Methylation in Colorectal Carcinoma.
    Kumar A; Gosipatala SB; Pandey A; Singh P
    Asian Pac J Cancer Prev; 2019 May; 20(5):1571-1577. PubMed ID: 31128064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas.
    Paluszczak J; Hemmerling D; Kostrzewska-Poczekaj M; Jarmuż-Szymczak M; Grenman R; Wierzbicka M; Baer-Dubowska W
    J Oral Pathol Med; 2014 Oct; 43(9):652-7. PubMed ID: 24762262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Wnt antagonist sFRP1 in colorectal tumorigenesis.
    Caldwell GM; Jones C; Gensberg K; Jan S; Hardy RG; Byrd P; Chughtai S; Wallis Y; Matthews GM; Morton DG
    Cancer Res; 2004 Feb; 64(3):883-8. PubMed ID: 14871816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of secreted Wnt-antagonist genes hypermethylation in early detection of colorectal tumor].
    Qi J; Zhu YQ; Luo J; Tao WH
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1954-7. PubMed ID: 17923031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norcantharidin inhibits Wnt signal pathway via promoter demethylation of WIF-1 in human non-small cell lung cancer.
    Xie J; Zhang Y; Hu X; Lv R; Xiao D; Jiang L; Bao Q
    Med Oncol; 2015 May; 32(5):145. PubMed ID: 25814287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma.
    Kohno H; Amatya VJ; Takeshima Y; Kushitani K; Hattori N; Kohno N; Inai K
    Oncol Rep; 2010 Aug; 24(2):423-31. PubMed ID: 20596629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low SFRP1 Expression Correlates with Poor Prognosis and Promotes Cell Invasion by Activating the Wnt/β-Catenin Signaling Pathway in NPC.
    Ren XY; Zhou GQ; Jiang W; Sun Y; Xu YF; Li YQ; Tang XR; Wen X; He QM; Yang XJ; Liu N; Ma J
    Cancer Prev Res (Phila); 2015 Oct; 8(10):968-77. PubMed ID: 26276746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analyses and prognostic significance of SFRP1 expression in bladder cancer.
    Rogler A; Kendziorra E; Giedl J; Stoehr C; Taubert H; Goebell PJ; Wullich B; Stöckle M; Lehmann J; Petsch S; Hartmann A; Stoehr R
    J Cancer Res Clin Oncol; 2015 Oct; 141(10):1779-90. PubMed ID: 25732201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients.
    Rawson JB; Manno M; Mrkonjic M; Daftary D; Dicks E; Buchanan DD; Younghusband HB; Parfrey PS; Young JP; Pollett A; Green RC; Gallinger S; McLaughlin JR; Knight JA; Bapat B
    Carcinogenesis; 2011 May; 32(5):741-7. PubMed ID: 21304055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas.
    Voorham QJ; Janssen J; Tijssen M; Snellenberg S; Mongera S; van Grieken NC; Grabsch H; Kliment M; Rembacken BJ; Mulder CJ; van Engeland M; Meijer GA; Steenbergen RD; Carvalho B
    BMC Cancer; 2013 Dec; 13():603. PubMed ID: 24350795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-339 and especially miR-766 reactivate the expression of tumor suppressor genes in colorectal cancer cell lines through DNA methyltransferase 3B gene inhibition.
    Afgar A; Fard-Esfahani P; Mehrtash A; Azadmanesh K; Khodarahmi F; Ghadir M; Teimoori-Toolabi L
    Cancer Biol Ther; 2016 Nov; 17(11):1126-1138. PubMed ID: 27668319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of WIF-1 and Wnt5a in patients with colorectal carcinoma: clinical significance.
    Abdelmaksoud-Dammak R; Miladi-Abdennadher I; Saadallah-Kallel A; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
    Tumour Biol; 2014 Aug; 35(8):7975-82. PubMed ID: 24833087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research progress of Wif1 in development of nervous system].
    Hu YA; Zhao CJ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 39(1):93-6. PubMed ID: 20175243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma.
    Kaur P; Mani S; Cros MP; Scoazec JY; Chemin I; Hainaut P; Herceg Z
    Tumour Biol; 2012 Apr; 33(2):325-36. PubMed ID: 22351518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1.
    Vassallo I; Zinn P; Lai M; Rajakannu P; Hamou MF; Hegi ME
    Oncogene; 2016 Jan; 35(1):12-21. PubMed ID: 25772239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.